Takeda Pharmaceutical Li... (TAK)
NYSE: TAK
· Real-Time Price · USD
14.97
0.17 (1.15%)
At close: Aug 15, 2025, 9:58 AM
Takeda Pharmaceutical Income Statement
Financials in JPY. Fiscal
year is
April - March.
Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 |
Revenue | 1,053.4B | 1,144.1B | 1,176B | 1,208B | 1,050.9B | 1,111.2B | 1,043.1B | 1,058.6B | 956.16B | 1,096.6B | 1,002.3B | 972.47B | 873.29B | 901.29B | 844.82B | 949.6B |
Cost of Revenue | 382.1B | 416.87B | 536.73B | 549.78B | 569.25B | 379.48B | 343.58B | 321.11B | 309.77B | 335.97B | 305.44B | 292.88B | 308.38B | 281.4B | 275.8B | 241.26B |
Gross Profit | 671.3B | 727.25B | 639.31B | 658.21B | 481.62B | 731.71B | 699.51B | 737.5B | 646.38B | 760.58B | 696.86B | 679.58B | 564.91B | 619.89B | 569.02B | 708.34B |
Operating Income | -74.9B | 66.94B | 184.25B | 219.71B | 534M | 104.91B | -49.34B | 168.57B | 88.56B | 146.99B | 104.44B | 150.51B | -1.62B | 116.48B | 97.43B | 248.55B |
Interest Income | n/a | n/a | 4.12B | 30.68B | 5.99B | 21.79B | 9.36B | 26.45B | 7.78B | 41.68B | 14.78B | 60.92B | n/a | 4.14B | 6.86B | 45.85B |
Pretax Income | -107.3B | 26.41B | 119.37B | 137.32B | -51.26B | 61.26B | -95.98B | 135.03B | 47.91B | 107.15B | 64.55B | 155.47B | -54.05B | 72.19B | 61.45B | 222.98B |
Net Income | -103.2B | 23.79B | 92.05B | 95.25B | -3.02B | 105.72B | -48.03B | 89.39B | 31.13B | 119.13B | 61.74B | 105.01B | -11.36B | 57.77B | 45.96B | 137.68B |
Selling & General & Admin | 295.9B | 270.59B | 268.28B | 270.03B | 285.23B | 267.52B | 252.95B | 248.11B | 254.8B | 262.3B | 248.73B | 231.48B | 223.43B | 231.08B | 212.01B | 219.84B |
Research & Development | 216B | 170.19B | 175.56B | 168.46B | 195.86B | 187.38B | 183.95B | 162.74B | 160.94B | 174.63B | 154.15B | 143.61B | 143.63B | 128.38B | 131.6B | 122.48B |
Other Expenses | 234.3B | 219.53B | n/a | n/a | n/a | -1.21B | n/a | n/a | n/a | -1.01B | n/a | 153.98B | 199.47B | 143.95B | 127.98B | 117.46B |
Operating Expenses | 746.2B | 660.31B | 443.85B | 438.49B | 481.09B | 665.29B | 748.85B | 568.93B | 557.82B | 613.59B | 592.42B | 529.07B | 566.53B | 503.4B | 471.6B | 459.79B |
Interest Expense | n/a | n/a | 68.45B | 59.69B | 47.19B | 66.57B | 46.52B | 59.58B | 42.93B | 79.75B | 53.8B | 55.47B | n/a | 46.71B | 39.68B | 71.07B |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 1,128.3B | 1,077.2B | 980.57B | 988.28B | 1,050.3B | 1,044.8B | 1,092.4B | 890.05B | 867.59B | 949.56B | 897.87B | 821.95B | 874.91B | 784.81B | 747.39B | 701.05B |
Income Tax Expense | -4.2B | 2.57B | 27.27B | 41.3B | -44.53B | -44.5B | -48.01B | 45.63B | 16.78B | -12B | 2.82B | 50.45B | -42.67B | 14.37B | 15.45B | 85.25B |
Shares Outstanding (Basic) | 3.16B | 3.17B | 3.17B | 3.14B | 3.14B | 3.14B | 3.13B | 3.11B | 3.11B | 3.11B | 3.1B | 3.09B | 3.11B | 3.13B | 3.14B | 3.09B |
Shares Outstanding (Diluted) | 3.16B | 3.17B | 3.22B | 3.18B | 3.14B | 3.17B | 3.13B | 3.13B | 3.23B | 3.14B | 3.13B | 3.11B | 3.15B | 3.15B | 3.16B | 3.11B |
EPS (Basic) | -32.62 | 7.51 | 29.07 | 30.36 | -0.96 | 33.69 | -15.34 | 28.76 | 10.02 | 38.32 | 19.89 | 33.97 | -3.65 | 18.45 | 14.62 | 44.54 |
EPS (Diluted) | -32.62 | 7.51 | 28.59 | 29.97 | -0.96 | 33.35 | -15.34 | 28.56 | 9.65 | 37.93 | 19.74 | 33.78 | -3.6 | 18.34 | 14.54 | 44.29 |
EBITDA | 181.27B | 193.01B | 380.28B | 384.55B | 187.28B | 291.98B | 200.26B | 347.9B | 257.76B | 323.87B | 272.26B | 323.04B | 131.41B | 263.77B | 238.07B | 391.55B |
EBIT | -8.5B | 6.05B | 187.83B | 196.29B | -100.65B | 127.83B | -37.96B | 194.61B | 38.12B | 186.9B | 118.35B | 210.94B | -20.87B | 118.9B | 101.12B | 294.05B |
Depreciation & Amortization | 189.77B | 186.96B | 192.45B | 192.22B | 186.74B | 187.06B | 240.24B | 171.5B | 161.41B | 176.88B | 167.83B | 158.28B | 152.27B | 147.28B | 140.65B | 142.95B |